Announce Date | 05/06/2025 |
EPS Normalized Actual | $1.81 (Miss by $-0.36) |
EPS GAAP Actual | $1.81 (Miss by $-0.36) |
Revenue Actual | $1.856B |
Revenue Surprise | Beat by $1856M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.74336 |
EPS GAAP Estimate | $2.74336 |
Revenue Estimate | $1.8763362B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 13.44719 | 9.48 | 12.94389 | 14.28122 | 1 |
Dec 2026 | 13.35 | 9.55 | 13.10966 | 13.68344 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.84 | 1.84 | 1.856B | -2.69% | 1856M |
FQ4 2024 (Dec 2024) | 3.039 | 3.039 | 2.148B | 3.03% | 2148M |
FQ3 2024 (Sep 2024) | 0 | 0 | 2.369B | 8.65% | 2369M |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 1.886B | 2.44% | 1886M |
FQ1 2024 (Mar 2024) | 2.89 | 2.89 | 1.906B | 8.71% | 1906M |
FQ4 2023 (Dec 2023) | 3.14 | 3.14 | 2.083B | 7.39% | 2083M |
FQ3 2023 (Sep 2023) | 2.1 | 2.1 | 2.164B | 8.32% | 2164M |
FQ2 2023 (Jun 2023) | 2.36 | 2.36 | 1.84B | 16.36% | 1840M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.74336
Consensus Revenue Estimates
1.8763362B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.87111 | -- | 3.59238 | 4.088 | 3 |
FQ3 2027 (Sep 2027) | 3.38374 | -- | 3.1401 | 3.57333 | 3 |
FQ2 2027 (Jun 2027) | 2.88161 | -- | 2.67412 | 3.04306 | 3 |
FQ1 2027 (Mar 2027) | 3.31073 | -- | 3.07235 | 3.49623 | 3 |
FQ4 2026 (Oct 2026) | 3.5117 | -- | 3.38558 | 3.79664 | 3 |
FQ3 2026 (Jul 2026) | 2.8344 | -- | 2.7326 | 3.06438 | 3 |
FQ2 2026 (Jun 2026) | 2.8511 | -- | 2.79503 | 2.96793 | 3 |
FQ1 2026 (Mar 2026) | 3.3639 | 45.3 | 3.29774 | 3.50175 | 3 |
FQ4 2025 (Oct 2025) | 2.79984 | -8.54 | 2.69929 | 3.02702 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.72B | -- | 1.62B | 1.79B | 2 |
FQ3 2027 (Sep 2027) | 2.66B | -- | 2.51B | 2.77B | 2 |
FQ2 2027 (Jun 2027) | 1.89B | -- | 1.79B | 1.97B | 2 |
FQ1 2027 (Mar 2027) | 1.84B | -- | 1.74B | 1.92B | 2 |
FQ4 2026 (Oct 2026) | 2.48B | -- | 2.41B | 2.64B | 2 |
FQ3 2026 (Jul 2026) | 1.96B | -- | 1.91B | 2.08B | 2 |
FQ2 2026 (Jun 2026) | 1.95B | -- | 1.92B | 2.01B | 2 |
FQ1 2026 (Mar 2026) | 1.72B | -7.98 | 1.69B | 1.77B | 2 |
FQ4 2025 (Oct 2025) | 2.02B | -6.44 | 1.96B | 2.14B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.84 | 1.84 | 100% | |
FQ4 2024 (Dec 2024) | 3.039 | 3.039 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 2.49 | 2.49 | 100% | |
FQ1 2024 (Mar 2024) | 2.89 | 2.89 | 100% | |
FQ4 2023 (Dec 2023) | 3.14 | 3.14 | 100% | |
FQ3 2023 (Sep 2023) | 2.1 | 2.1 | 100% | |
FQ2 2023 (Jun 2023) | 2.36 | 2.36 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.86B | $1856M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.15B | $2148M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.37B | $2369M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.89B | $1886M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.91B | $1906M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.08B | $2083M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.16B | $2164M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.84B | $1840M | 100% |